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1. Introduction 
A decapeptide capable to stimulate the release of 
LH and FSH from pituitary has been recently isolated 
from hypothalami of porcine origin and its amino acid 
sequence has been established as (Pyro)Glu-His- 
Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH, [ 1,2]. 
An identical decapeptide has been found in sheep 
hypothalami [ 3,4] . 
Several laboratories described syntheses of 
LH-RH/FSH-RH either by the solid phase technique 
[5, 81 or by the classical approach [9, lo] . 
Previous studies in our laboratory have permitted 
the tritiation of several peptidic hormones with sub- 
sequent retention of their biological activities. The 
method used, described by Morgat et al. [ 11, 121, 
consists in a catalytic hydrogenolysis of iodinated 
tyrosyl residue(s). Recently, by a similar procedure, 
Pradelles et al. [ 131 and Menez et al. [ 141 have 
obtained [3H]TRH and Nuja nigricollis [3H]a-neuro- 
toxin, respectively, in which the histidyl side chain 
carried the label. 
The present report describes the tritium labelling 
of LH-RH/FSH-RH. The product had a specific radio. 
activity of 75 Ci/mmole, it was biologically active on 
the release of both LH and FSH, and not distinct in 
this respect from the unlabelled decapeptide. 
2. Experimental 
2.1. Materials 
LH-RH/FSH-RH synthesized via the classical 
approach of peptide synthesis [lo] was generously 
supplied by Drs. R.O. Studer and D. Gillessen 
(Hoffman-La Roche, Basel). The final material was 
purified by partition chromatography on Sephadex 
G-25 using 1-butanol-ethanol-pyridine-0.2 N 
acetic acid (4: 1: 1:7) as solvent system [lo]. ICl used 
for the halogenation was from Rh6ne Poulenc (Paris) 
and “‘ICl used as tracer, from New-England Nuclear 
Corporation. The catalyst Pd/Al,O, (10%) was sup- 
plied by Engelhardt (Roma), the ion exchange resins 
AG 11 A8 and Bio-gel P2 by BioRad laboratories. 
Tritium gas was made by the Commissariat 3 
1’Energie Atomique (France). Tritium determinations 
were made with a Nuclear-Chicago liquid scintillation 
counter and “‘1 was counted with SAIP-Gammatic 
solid scintillation device. [3H]LH-RH/FSH-RH was 
stored in liquid N,. 
2.2. Iodinution of LH-RHfFSH-RH 
Iodination was accomplished at 4O; 4.3 pmoles ICI 
(100 ~1 of anhydrous methanolic solution in the 
presence of ‘2JIC1 as tracer) were slowly added to 
1.1 wales (1.3 mg) LH-RH/FSH-RH dissolved in 1 ml 
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0.1 M phosphate buffer pH 7.4. The reaction was 
stopped by addition of 50 4 0.1 M Na thiosulfate 
solution. By paper electrophoresis of a reaction 
aliquot (pyridine-acetic acid 0.075 M, pH 6.5, 12 
V/cm), 2.5 iodine atoms were found incorporated 
per mole LH-RH/FSH-RH. The iodinated mixture was 
purified by passage through an AG 11 A8 column 
which removed the salt. Its UV spectrum showed 
i) no alteration of the tryptophan residue and ii) the 
presence of a di-iodotyrosyl residue (maximum at 
312 nm at pH 11). With respect to the amount of 
iodine atoms bound to the peptide, it appeared that 
the histidyl residue was also partially iodinated. 
2.3. Tritiation 
After lyophilization, iodc+LH-RH/FSH-RI-I 
redissolved in 1 ml glacial AcOH, was transferred to 
the tritiation flask and then frozen. 10 mg of catalyst 
Pd/Al,O, were added and the tritiation flask was 
connected to the vacuum. At a pressure of 10m4 Torr, 
10 Ci of pure tritium gas were introduced (500 Torr). 
The mixture was thawed and stirred for 0.5 hr. 
Millipore filtration was employed for removal of the 
catalyst followed by successive flash evaporation for 
exchange of labile hydrogens. 
2.4. Purification 
The [‘HILI-I-RH/FSH-RH mixture was filtered on 
a Bio-gel P2 column (50-100 mesh, eluted by 
10m2 M AcOH). Elution profiles were monitored by 
absorbance at 280 nm and by 3H and “‘1 counting. 
These analyses and amino acid measurements with the 
Technicon auto-analyzer indicated recovery of 
180 pug [3H]LH-RH/FSH-RH. This product was 
iodine-free and its specific radioactivity was 75 
Ci/mmole. 
The chemical purity was verified by thin-layer 
chromatography (Cellulose MN 300, nBuOH/AcOH/H,O 
75: 10:25, v/v/v) and scanning; the UV spectrum of 
the [‘H]LH-RH/FSH-RH was found to be exactly 
the same as that of the original material. 
2.5. Biological assays 
Biological assays for measuring the hypothalamic 
releasing hormone activity were performed using in- 
direct methods involving a 2-step system: i) action on 
the in vitro release of gonadotropins from the pitui- 
tary, ii) the radioimmunoassay of gonadotropins. 
84 
Hemipituitaries (4 per flask) from ovariectomized, 
steroid primed rats [ 151 were rinsed twice with 2 ml 
of Krebs-Ringer bicarbonate-glucose buffer (KRB) 
and “pre-incubated” for a period of 30 min in 2 ml 
of the same medium saturated with 93% 0, /7% CO,. 
After changing the medium, incubation proceeded 
for 4 hr period in 2 ml of KRB containing none or 
various doses of unlabelled or tritiated LH-RH/FSH-RH 
[W. 
Following incubation, groups of hemipituitaries 
were weighted within 0.05 mg. Rat LH and FSH were 
measured in incubation medium using radioimmuno- 
assays previously described [ 17, 181 .
Table 1 shows the release of LH and FSH from rat 
pituitaries under the action of both unlabelled and 
labelled LH-RH/FSH-RH assayed 10 days and 60 
days after tritiation. No significant difference was 
found between tritiated and non tritiated products. 
3. Discussion 
The analytical, spectral and biological characteris- 
tics indicate that the labelled peptide is indistinguish- 
able from the unlabelled one. The tritium radioactivity 
is in agreement with the incorporation of 2.5 iodine 
atoms per mole LH-RH/FSH-RH and their quantita- 
tive replacement by 2.5 tritium atoms. This confirms 
the fact that ICl has reacted not only with the tyrosyl 
but also with the histidyl residue. It is worth pointing 
out that the [3H]LH-RH/FSH-RH tryptophyl residue 
has not been oxidized during the halogenation step. In 
parallel experiments, free tryptophan and tryptophan t 
glutathione mixtures, have been treated with ICl 
under similar conditions. The indole moiety was irn- 
mediately altered as indicated by a pink coloration 
which appeared and remained after thiosulfate 
addition. The resistance of the tryptophan side chain 
of LH-RH/FSH-RH to the oxidizing action of ICl may 
correspond either to the much faster reaction rate of 
ICI with the tyrosine and histidine side chains or to 
the inaccessibility of the tryptophan side chain to the 
reagent. The latter possibility appears more likely as 
an excess of ICI was used, and suggests in the peptide 
a specific environment for the tryptophan, an essential 
residue for the biological activity of the molecule [ 191. 
Thus, as in the case of the ZVaja nigricollis ~1 
neurotoxin [ 141, tryptophan containing peptides 
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Table 1 
Effect of unIabelled and labelled LH-RH/FSH-RH on the in vitro release of LH and FSH from rat pituitary glands’. 
~______ 
LH-RH/FSH-RH pg LH released’/mg of tissue pg FSH released3/mg of tissue 
(nglml) UnlabeIIed LH-RH/FSH-RH [3H]LH-RH/FSH-RH UnlabeIIed LH-RH/FSH-RH [3H]LH-RH/FSH-RH 
Assayed 10 days after tritia&m4 
Control 0.58 ? 0.13 0.06 ? 0.020 
1 1.24 f 0.13 1.06 + 0.07 0.11 * 0.01 0.13 f 0.010 
10 1.35 f 0.12 1.50 i 0.15 0.17 f 0.015 0.15 0.013 f 
100 2.09 * 0.20 1.97 f 0.20 0.31 f 0.03 0.24 0.030 f 
Assayed 60 days after tritiation4 
Control 0.40 f 0.1 0.03 f 0.007 
1 0.73 i 0.08 0.77 * 0.07 0.07 f 0.007 0.06 i 0.005 
10 1.60 i 0.16 1.88 f 0.19 0.11 f 0.01 0.12 f 0.009 
100 1.80 * 0.20 1.83 i 0.18 0.11 * 0.01 0.12 f 0.006 
1 In each case 4 pituitary halves (per flask) of ovariectomized female rats treated with estradiol benzoate and progesterone (EBP) 
were incubated for 4 hr. 
2 In terms of a rat LH laboratory preparation (1 X NIH-LH S3). 
3 In terms of a rat FSH (FSH-S-1-1, 100 X NIH-FSH-Sl) supplied by the NLAMD. 
4 The product was stored in liquid nitrogen. 
may survive the halogenation step required for the 
present tritiation method. 
Lastly, it may be mentioned that after two months 
of storage in liquid N,, [3H]LH-RH/FSH-RH retained 
both its chemical and biological properties. 
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